U.S. Markets closed

LogicBio Therapeutics, Inc. (LOGC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.64-0.11 (-1.91%)
At close: 4:00PM EDT

5.64 0.00 (0.00%)
After hours: 4:02PM EDT

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.99
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 311.60
52 Week Low 33.05
50-Day Moving Average 36.57
200-Day Moving Average 37.06

Share Statistics

Avg Vol (3 month) 3173.03k
Avg Vol (10 day) 3195.61k
Shares Outstanding 531.74M
Float 11.44M
% Held by Insiders 121.14%
% Held by Institutions 168.23%
Shares Short (Sep 29, 2020) 4486.64k
Short Ratio (Sep 29, 2020) 42.44
Short % of Float (Sep 29, 2020) 43.75%
Short % of Shares Outstanding (Sep 29, 2020) 42.05%
Shares Short (prior month Aug 30, 2020) 4196.04k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-2,002.42%

Management Effectiveness

Return on Assets (ttm)-43.09%
Return on Equity (ttm)-87.51%

Income Statement

Revenue (ttm)1.99M
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -39.36M
Net Income Avi to Common (ttm)-40.06M
Diluted EPS (ttm)-1.74
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)36.7M
Total Cash Per Share (mrq)1.55
Total Debt (mrq)16.31M
Total Debt/Equity (mrq)57.92
Current Ratio (mrq)9.60
Book Value Per Share (mrq)1.20

Cash Flow Statement

Operating Cash Flow (ttm)-37.63M
Levered Free Cash Flow (ttm)-24.01M